Cochrane Review
A systematic review published by the Cochrane Collaboration, widely considered the gold standard for evidence-based healthcare decision-making. Cochrane reviews follow rigorous, standardised methodology and are regularly updated as new evidence becomes available.
Technical Context
Cochrane Collaboration operates through review groups specialising in disease areas. Cochrane Reviews follow the most rigorous methodology: comprehensive search strategy (including grey literature), duplicate screening, validated risk of bias assessment (Cochrane RoB 2 tool), GRADE evidence certainty ratings, and mandatory update schedules. Cochrane protocols are published prospectively (registered before the review is conducted, preventing selective outcome reporting). The Cochrane Library publishes over 8,000 reviews. Cochrane Reviews of peptide therapeutics (e.g. GLP-1 RAs for T2D, somatostatin analogues for acromegaly, GnRH agonists for prostate cancer) are regarded as the highest-quality evidence syntheses and are directly referenced by guideline committees (NICE, ADA, EASD) in formulating treatment recommendations.